PENERAPAN TRANSTHEORICAL MODEL BEHAVIORAL CHANGE TERHADAP KEPATUHAN BEROBAT PADA PASIEN MULTIDRUG RESISTANT TUBERCULOSIS DI PUSKESMAS KOTA DAN KABUPATEN JAYAPURA
Isi Artikel Utama
Abstrak
Multi Drug Resistant Tuberculosis (MDR-TB) is still a global health problem. Indonesia is the 3rd country with an average of 5% cases per 100,000 population. For the Papua region, MDR-TB is still a major problem because the treatment success rate has not reached the WHO indicator (68.7%). The treatment of MDR-TB is complex and time-consuming, making patients non-compliant. Reports of low patient visits have made it possible to develop a promotive service program based on applying the Transtheoretical Model (TTM) of Behavioral Change. The TTM Model focuses on changing behavior with the main component of self-efficacy. The study aimed to determine the characteristics of patients, treatment compliance of MDR-TB patients, analyze the effect of applying the TTM behavioral change model with the level of treatment compliance of MDR-TB patients. The research method used a pre-experiment design with a one-group pre-test-post-test design. The study population was 35 patients at the city and district health centers of Jayapura. The instruments used were the Self-Efficacy For Appropriate Medication Use Scale (SEAMS) and TB Medication Adherence Scale (TBMAS). The effect test used a paired sample t-test with significance level p-value=0.05. This indicates an effect of changes in compliance behavior after being given health promotion by applying the Transtheoretical Model. Substantially, the level of adherence to taking medication in MDR-TB patients is also influenced by belief and motivation to recover. There is support from nurses at the puskesmas who often provide behavior change promotions, so patients have the strength and support of a good system that has a positive impact on increasing thoughts to achieve recovery. The importance of Increasing health promotion based on behavior change in MDR-TB patients can increase self-efficacy to recover so that it has an impact on adherence to taking medication.
Rincian Artikel
Referensi
L. Puspitasari, B. Murti, and A. Demartoto, “Social Support on the Adherence to Treatment of Tuberculosis in Cilacap, Indonesia,” Multilevel Anal. Bio-psychosocial Environ. Factors Affect. Risk Pneumonia Infants, vol. 01, no. 01, pp. 58–65, 2016, doi: 10.26911/jepublichealth.2016.01.01.07.
L. B. Nellums, K. Rustage, S. Hargreaves, and J. S. Friedland, “Multidrug-resistant tuberculosis treatment adherence in migrants: A systematic review and meta-analysis,” BMC Med., vol. 16, no. 1, pp. 1–11, 2018, doi: 10.1186/s12916-017-1001-7.
S. Girirajan, C. Campbell, and E. Eichler, “Treatment Adherence among Persons Receiving Concurrent Multidrug-Resistant Tuberculosis and Human Immunodeficiency Virus Treatment in KwaZulu-Natal, South Africa Fay,” Physiol. Behav., vol. 176, no. 5, pp. 139–148, 2011, doi: 10.1097/QAI.0000000000002120.Treatment.
WHO, TB burden report 2018, vol. 63, no. 10. 2018. [Online]. Available: https://apps.who.int/iris/handle/10665/274453
K. Dheda et al., “The epidemiology, pathogenesis, transmission, diagnosis, and management of multidrug-resistant, extensively drug-resistant, and incurable tuberculosis,” Lancet Respir. Med., vol. 5, no. 4, pp. 291–360, 2017, doi: 10.1016/S2213-2600(17)30079-6.
E. Guanabara, K. Ltda, E. Guanabara, and K. Ltda, Global Tuberculosis Report. 2023.
S. Gandra et al., “The Mortality Burden of Multidrug-resistant Pathogens in India: A Retrospective, Observational Study,” Clin. Infect. Dis., vol. 69, no. 4, pp. 563–570, 2019, doi: 10.1093/cid/ciy955.
World Health Organization, Global tuberculosis report 2018. World Health Organization. http://www.who.int/iris/handle/10665/274453. 2018.
J. C. Parrenas, K. Waller, and N. Sinsiri, “Executive Summary,” Dev. Bond Mark. APEC, pp. ix–xiv, 2018, doi: 10.1355/9789812306395-002.
M. Sans Frontieres, “Out of Step 2017, TB Policies in 29 Countries A survey of prevention, testing and treatment policies and practices,” p. 31, 2017, [Online]. Available: http://stepupfortb.org/%0A*Diagnosed
Kemenkes RI, “Strategi Nasional Penanggulangan Tuberkulosis di Indonesia 2020-2024,” Pertem. Konsolidasi Nas. Penyusunan STRANAS TB, p. 135, 2020.
P. Kemenkes, Temukan TB Obati Sampai Sembuh Penatalaksanaan Tuberkulosis Resisten Obat di Indonesia. 2020.
Kementerian Kesehatan RI, “Health Statistics (Health Information System),” Short Textb. Prev. Soc. Med., pp. 28–28, 2019, doi: 10.5005/jp/books/11257_5.
T. Schaberg and H. Lode, “Treatment of tuberculosis,” Dtsch. Medizinische Wochenschrift, vol. 115, no. 47, pp. 1799–1802, 1990, doi: 10.1055/s-2008-1065229.
F. S. Nugroho, “Analisis Ketidakpatuhan Pengobatan Pasien TB-MDR Fase Intensif di Rumah Sakit X Surakarta,” J. Ilmu Kesehat. Masy. Berk., vol. 1, no. 1, p. 54, 2019, doi: 10.32585/jikemb.v1i1.698.
Kemenkes RI, “TB di Era COVID-19,” Bul. Elimin. Tuberc., vol. 1, pp. 1–21, 2020, [Online]. Available: https://tbindonesia.or.id/wp-content/uploads/2020/08/Buletin-Eliminasi-TBC_Volum-1_2020_Final.pdf
W. Xing et al., “Adherence to multidrug resistant tuberculosis treatment and case management in chongqing, china – a mixed method research study,” Infect. Drug Resist., vol. 14, pp. 999–1012, 2021, doi: 10.2147/IDR.S293583.
S. Sulistiyani, L. Situmeang, and Q. Nur, “Psychological of the Patient Multi Drug Resistan Tuberculosis During,” Keperawatan Trop. Jayapura, vol. 04, 2021.
Z. S. Nezenega, L. Perimal‐lewis, and A. J. Maeder, “Factors influencing patient adherence to tuberculosis treatment in ethiopia: A literature review,” Int. J. Environ. Res. Public Health, vol. 17, no. 15, pp. 1–12, 2020, doi: 10.3390/ijerph17155626.
A. Zegeye et al., “Prevalence and determinants of anti-tuberculosis treatment non-adherence in Ethiopia: A systematic review and meta-analysis,” PLoS One, vol. 14, no. 1, 2019, doi: 10.1371/journal.pone.0210422.
WHO, “Global Tuberculosis Report,” 2020.
C. Shiming, “Current situation and recommendation of MDR-TB prevention and control in China,” China Trop Med. 2017;17(3)213–215, vol. 17, no. 3, pp. 213–215, 2017, doi: 10.13604/j.cnki.46-1064/r.2017.03.01.
M. Loveday et al., “Community-based care vs. centralised hospitalisation for MDRTB patients, KwaZulu-Natal, South Africa,” Int. J. Tuberc. Lung Dis., vol. 19, no. 2, pp. 163–171, 2015, doi: 10.5588/ijtld.14.0369.
P. P. Wai et al., “Community-based MDR-TB care project improves treatment initiation in patients diagnosed with MDR-TB in Myanmar,” PLoS One, vol. 13, no. 3, 2018, doi: 10.1371/journal.pone.0194087.
J. O. Prochaska et al., “Initial Efficacy of MI, TTM Tailoring and HRI’s with Multiple Behaviors for Employee Health Promotion,” Bone, vol. 78, no. 2, pp. 711–716, 2012, doi: 10.1016/j.ypmed.2007.11.007.Initial.
W. F. Velicer, J. L. Fava, J. O. Prochaska, G. J. Norman, and C. A. Reading, “Detailed Overview of the Transtheoretical Model,” 2005, [Online]. Available: http://www.uri.edu/research/cprc/TTM/detailedoverview.htm
S. Selvaraj and S. Ramakrishnappa, “Transtheoretical Model of Behavioural Change,” Int. J. Pharm. Res., vol. 13, no. 02, 2021, doi: 10.31838/ijpr/2021.13.02.081.
J. O. Prochaska and W. F. Velicer, “The transtheoretical model of health behavior change,” Am. J. Heal. Promot., vol. 12, no. 1, pp. 38–48, 1997, doi: 10.4278/0890-1171-12.1.38.
D. F. Polit and C. T. Beck, Nursing research generating and assessing evidence for nursing practice, Ninth. Lippincott Williams & Wilkins, 2012.
N. M. Adiutama, A. K. Fauzi, and A. D. Ellina, “Intervensi Edukasi Berbasis Theory of Planned Behavior Untuk Meningkatkan Kepatuhan Pengobatan, Nutrisi, Dan Pencegahan Penularan Pada Pasien Tuberkulosis,” J. Ilm. Keperawatan (Scientific J. Nursing), vol. 7, no. 1, pp. 117–126, 2021, doi: 10.33023/jikep.v7i1.724.
J. Risser, T. A. Jacobson, and S. Kripalani, “Development and Psychometric Evaluation of the Self-Efficacy for Appropriate Medication Use Scale (SEAMS) in Low-Literacy Patients With Chronic Disease,” J. Nurs. Manag., vol. 12, no. 1, pp. 32–44, 2007.
J. Yin, X. Wang, L. Zhou, and X. Wei, “The relationship between social support, treatment interruption and treatment outcome in patients with multidrug-resistant tuberculosis in China: a mixed-methods study,” Trop. Med. Int. Heal., vol. 23, no. 6, pp. 668–677, 2018, doi: 10.1111/tmi.13066.
Ahmadi and A. R. Hakim, “Self-Efficacy and Selected Demographics As Determinants of the Family Behavior on Examination for Patients With Tuberculosis in Pamekasan,” J. Kerta Cendekia, vol. 1, no. 1, pp. 122–132, 2019, [Online]. Available: http://repository.unira.ac.id/id/eprint/264
T. Sukartini, I. Minarni, and C. P. Asmoro, “Family Support, Self-efficacy, Motivation, and Treatment Adherence in Multidrug-resistant Tuberculosis Patients,” no. Inc, pp. 178–182, 2019, doi: 10.5220/0008322301780182.
R. Patel and S. Chauhan, “Gender differential in health care utilisation in India,” Clin. Epidemiol. Glob. Heal., vol. 8, no. 2, pp. 526–530, 2020, doi: 10.1016/j.cegh.2019.11.007.
G. M. P. Castro, F. N. M. Zuluaga, J. E. Alcalde-Rabanal, and F. Pérez, “Patient- And provider-related factors in the success of multidrug-resistant tuberculosis treatment in Colombia*,” Rev. Panam. Salud Publica/Pan Am. J. Public Heal., vol. 45, no. 1, pp. 1–9, 2021, doi: 10.26633/RPSP.2021.74.
S. Chowdhury and P. pratim Chakraborty, “Universal health coverage ‑ There is more to it than meets the eye,” J. Fam. Med. Prim. Care, vol. 6, no. 2, pp. 169–170, 2017, doi: 10.4103/jfmpc.jfmpc.
D. T. Myemba et al., “Clinical characteristics and treatment outcomes of patients with MDR tuberculosis in Dar Es Salaam region, Tanzania,” JAC-Antimicrobial Resist., vol. 2, no. 4, pp. 1–8, 2021, doi: 10.1093/jacamr/dlaa108.
C. Finn McQuaid, K. C. Horton, A. S. Dean, G. M. Knight, and R. G. White, “The risk of multidrug- or rifampicin-resistance in males versus females with tuberculosis,” Eur. Respir. J., vol. 56, no. 3, 2020, doi: 10.1183/13993003.00626-2020.
E. Setiyowati, H. Hardiyanti, F. A. Setiawan, and P. Susilo, “Overview Self-Efficacy and Self-Acceptance in Tuberculosis Sufferers,” Med. Heal. Sci. J., vol. 5, no. 2, pp. 9–15, 2021, doi: 10.33086/mhsj.v5i2.2160.
E. D. Noorratri, A. Margawati, and M. Dwidiyanti, “Improving Self-Efficacy and Physical Self-Reliance of Patients with Pulmonary Tuberculosis through Mindfulness,” Nurse Media J. Nurs., vol. 6, no. 2, p. 81, 2017, doi: 10.14710/nmjn.v6i2.12585.
Z. Kanjee, K. R. Amico, F. Li, K. Mbolekwa, A. P. Moll, and G. H. Friedland, “Tuberculosis infection control in a high drug-resistance setting in rural South Africa: Information, motivation, and behavioral skills,” J. Infect. Public Health, vol. 5, no. 1, pp. 67–81, 2012, doi: 10.1016/j.jiph.2011.10.008.